Haoxi Health Technology Ltd (HAO): R&D Expense
$104.4K
Year ended 2026-06-30
+21.5%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $104.4K | +31.2% | 2026-09-30, From 2025-07-01 |
| 2025-06-30 | $79.5K | -0.6% | 2026-09-30, From 2024-07-01 |
| 2024-06-30 | $80.0K | +37.5% | 2026-09-30, From 2023-07-01 |
| 2023-06-30 | $58.2K | -43.3% | 2025-10-20, From 2022-07-01 |
| 2022-06-30 | $102.5K | n/a | 2024-10-29, From 2021-07-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Haoxi Health Technology Ltd (HAO) | 2026-06-30 | $104.4K | +31.2% |
| Criteo S.A. (CRTO) | 2025-12-31 | $283.30M | +1.4% |
Compare HAO, CRTO side by side · Screen every company in Services-Advertising Agencies ↗